8-K
Current Report
Foghorn Therapeutics Inc. Filed Acc 0001628280-26-064102
Exit or restructuring costs · Regulation FD disclosure
- Item 2.05 Costs associated with exit or disposal activities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading fhtx-20260925.htm…